<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18404454</article-id>
      <article-id pub-id-type="pmc">2072916</article-id>
      <article-id pub-id-type="publisher-id">9079</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-007-9079-6</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Guanosine reduces apoptosis and inflammation associated with restoration of function in rats with acute spinal cord injury</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Jiang</surname>
            <given-names>Shucui</given-names>
          </name>
          <address>
            <phone>+1-905-5212100</phone>
            <fax>+1-905-5219992</fax>
            <email>jiangs@mcmaster.ca</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bendjelloul</surname>
            <given-names>Farid</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ballerini</surname>
            <given-names>Patrizia</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>D&#x2019;Alimonte</surname>
            <given-names>Iolanda</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nargi</surname>
            <given-names>Elenora</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jiang</surname>
            <given-names>Cai</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Huang</surname>
            <given-names>Xinjie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rathbone</surname>
            <given-names>Michel P.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Surgery (Neurosurgery), McMaster University, Health Sciences Centre, 4N71B, 1200 Main Street West, Hamilton, L8N 3Z5 ON Canada </aff>
        <aff id="Aff2"><label>2</label>Department of Medicine (Neurology), McMaster University, Health Sciences Centre, 4N71B, 1200 Main Street West, Hamilton, L8N 3Z5 ON Canada </aff>
        <aff id="Aff3"><label>3</label>Department of Biomedical Sciences, Universita Degli Studi &#x201C;G. D&#x2019;Annunzio&#x201D;, University Of Chieti, Nuovo Polo Didattico, Via Dei Vestini, 31, Chieti, 66013 Italy </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>411</fpage>
      <lpage>421</lpage>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>6</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>8</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science + Business Media B.V. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>Spinal cord injury results in progressive waves of secondary injuries, cascades of noxious pathological mechanisms that substantially exacerbate the primary injury and the resultant permanent functional deficits. Secondary injuries are associated with inflammation, excessive cytokine release, and cell apoptosis. The purine nucleoside guanosine has significant trophic effects and is neuroprotective, antiapoptotic in vitro, and stimulates nerve regeneration. Therefore, we determined whether systemic administration of guanosine could protect rats from some of the secondary effects of spinal cord injury, thereby reducing neurological deficits. Systemic administration of guanosine (8&#xA0;mg/kg per day, i.p.) for 14&#xA0;consecutive days, starting 4&#xA0;h after moderate spinal cord injury in rats, significantly improved not only motor and sensory functions, but also recovery of bladder function. These improvements were associated with reduction in the inflammatory response to injury, reduction of apoptotic cell death, increased sparing of axons, and preservation of myelin. Our data indicate that the therapeutic action of guanosine probably results from reducing inflammation resulting in the protection of axons, oligodendrocytes, and neurons and from inhibiting apoptotic cell death. These data raise the intriguing possibility that guanosine may also be able to reduce secondary pathological events and thus improve functional outcome after traumatic spinal cord injury in humans.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Apoptosis</kwd>
        <kwd>Cell death</kwd>
        <kwd>Glia</kwd>
        <kwd>Guanosine</kwd>
        <kwd>Immunohistochemistry</kwd>
        <kwd>Inflammation</kwd>
        <kwd>Locomotor and sensory function</kwd>
        <kwd>Myelin</kwd>
        <kwd>Spinal cord injury</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Spinal cord injury (SCI) occurs in an instant, but its devastating effects last a lifetime at huge personal and economic cost [<xref ref-type="bibr" rid="CR1">1</xref>]. The spinal cord conveys both afferent sensory and efferent motor information, so disruption of spinal cord function results not only in motor paralysis but also sensory and autonomic impairment distal to the injury [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Sensory dysfunction contributes to the generation of pressure sores that, like bladder impairment, are a major source of morbidity and even mortality in those with spinal cord injury [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
      <p>Restoration of function in longstanding spinal cord injuries is poor, although some limited functional restoration has been reported [<xref ref-type="bibr" rid="CR5">5</xref>]. Therefore, there is much interest in reducing the extent of the initial damage from traumatic spinal cord injury in the acute phase. Trauma often results in primary damage resulting from mechanical disruption of the nerve axons in the spinal cord that is not amenable to neuroprotective therapy. However, secondary pathological changes involving cascades of biochemical, molecular, and cellular changes can produce even more extensive damage, and these changes are potentially susceptible to therapeutic intervention with neuroprotective agents [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Thus, pathological changes occur from the moment of injury and continue for years afterwards and have been divided into three phases: an acute phase, a phase of secondary tissue loss, and a chronic phase [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>In the acute phase, which starts at the moment of injury and extends over the first few days, numerous pathological processes begin. Mechanical injury induces an immediate change in neuronal tracts at the moment of impact, blood flow is reduced, creating substantial ischemic necrosis [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] and a cascade of pathophysiological processes rapidly follows mechanical trauma to the spinal cord, resulting in secondary neuronal damage that can significantly exacerbate the original injury [<xref ref-type="bibr" rid="CR9">9</xref>]. Traumatic injury to the spinal cord also leads to a strong inflammatory response, with the recruitment of peripherally derived inflammatory cells, including macrophages [<xref ref-type="bibr" rid="CR10">10</xref>]. Damage to the spinal cord also results in extensive cell proliferation in and around the epicenter, many of which are microglia and macrophages. This acute inflammatory response at the site of the initial lesion is at least partly responsible for secondary spinal cord pathology [<xref ref-type="bibr" rid="CR11">11</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>]. The inflammatory cells (particularly macrophages/microglia) can mediate tissue damage by producing a variety of cytotoxic factors including interleukins [<xref ref-type="bibr" rid="CR14">14</xref>], tumor necrosis factor-alpha (TNF-alpha) [<xref ref-type="bibr" rid="CR15">15</xref>], and reactive nitrogen species [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR16">16</xref>&#x2013;<xref ref-type="bibr" rid="CR18">18</xref>]. Neuronal and oligodendroglial cell loss is apparent in the lesion epicenter, and rostral and caudal to it within 4&#xA0;h of injury [<xref ref-type="bibr" rid="CR19">19</xref>]. From days to years after the initial trauma, apoptotic cell death continues, and scarring and demyelination accompany Wallerian degeneration. All these processes contribute to motor and sensory functional deficits [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p>
      <p>Many pharmacological agents have been reported to reduce secondary injury and to be neuroprotective in a variety of animal models; these include anti-inflammatory [<xref ref-type="bibr" rid="CR22">22</xref>&#x2013;<xref ref-type="bibr" rid="CR24">24</xref>] and antiapoptotic agents [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] and agents that elevate cyclic adenosine monophosphate (cAMP) [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. None has yet proved effective in ameliorating the effects of acute spinal cord injury in clinical trials in humans.</p>
      <p>There is increasing evidence that the non-adenine-based purine guanosine acts as an intercellular signaling molecule. It is released from cells and has several diverse effects on cells in vivo and in vitro, particularly trophic effects modulating cellular growth, differentiation, and survival [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Guanosine has a number of effects on various cell types that make it a good candidate to test as a neuroprotective agent in acute spinal cord injury since it might potentially interact with several steps of the biochemical and cellular cascade. It is neuroprotective [<xref ref-type="bibr" rid="CR28">28</xref>&#x2013;<xref ref-type="bibr" rid="CR32">32</xref>] and stimulates nerve regeneration [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. It also protects several cell types against apoptosis induced by a variety of agents such as staurosporine [<xref ref-type="bibr" rid="CR34">34</xref>] and beta-amyloid [<xref ref-type="bibr" rid="CR35">35</xref>] and has been reported to increase intracellular cAMP [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Therefore, in the present study, we assessed whether guanosine might ameliorate tissue damage and enhance functional outcome after acute spinal cord injury.</p>
    </sec>
    <sec id="Sec2" sec-type="materials|methods">
      <title>Materials and methods</title>
      <sec id="Sec3">
        <title>Animals</title>
        <p>Adult female Wistar rats (280&#x2013;300&#xA0;g body weight, Charles River) were maintained in a temperature-controlled vivarium on a 12:12-h light-dark cycle with food and tap water freely available. Rats were handled daily for 2&#xA0;weeks before surgery.</p>
      </sec>
      <sec id="Sec4">
        <title>Spinal cord injury induction and experimental design</title>
        <p>Spinal cords were surgically exposed and compressed with modified coverslip forceps to produce a moderate traumatic spinal cord injury [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Before surgery, rats were given buprenorphine (0.03&#xA0;mg/kg body weight, subcutaneously) for pain relief. They were then anesthetized with isoflurane (3&#x2013;5%): O<sub>2</sub> (1&#xA0;l/min) and a laminectomy was performed at T11/T12 to expose the spinal cord that was then crushed with modified coverslip forceps [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR38">38</xref>&#x2013;<xref ref-type="bibr" rid="CR40">40</xref>]. The forceps were closed slowly (over 2&#xA0;s) compressing a 5-mm length of the spinal cord to a thickness of 1.4&#xA0;mm for 15&#xA0;s. The wound was closed by suturing the muscles and fat pad, and by clipping the skin with stainless steel clips. Postoperatively, the rats were kept quiet and warm.</p>
        <p>To evaluate the effect of guanosine on acute phase SCI pathophysiology, we studied two groups of rats (<italic>n</italic>&#x2009;=&#x2009;24) with SCI. After surgery and prior to treatment, behavioral tests were done for each rat. Two of the total 24 animals were excluded from the study because of incorrect injury (BBB score at the surgery day before treatment below 4 or above 7; in our experience, about 91% of rats with this degree of crush were within the range of 5 to 6 on the BBB scale at first day after injury [<xref ref-type="bibr" rid="CR38">38</xref>]). The 22 rats were then randomly divided into two groups. Starting 4&#xA0;h after surgery, rats received either daily intraperitoneal (i.p.) injections of 8&#xA0;mg/kg guanosine or the same volume of saline containing 0.001&#xA0;N NaOH [<xref ref-type="bibr" rid="CR5">5</xref>] for 2&#xA0;weeks. On day 7 after injury one animal in the saline group was euthanized because of a severe bladder infection.</p>
      </sec>
      <sec id="Sec5">
        <title>Motor and sensory functional recovery assessment</title>
        <p>All rats were handled daily for 2&#xA0;weeks preoperatively to acclimatize them to the handling and behavioral testing. After spinal cord compression, the locomotor behavior segmental reflexes and spinothalamic senses of the rats were assessed immediately prior to treatment (day 0) and on days 1, 3, 5, 7, 14, 21, and 28 after the injury. Five tests were used: an open field walking task [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>], hind limb placing response [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR40">40</xref>], foot orienting response [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>], an inclined plane test [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>], and a hot plate test [<xref ref-type="bibr" rid="CR46">46</xref>]. Behavioral analyses were performed by individuals who were blinded with respect to treatment groups.</p>
        <p>An open field walking testing (OFWT) was used to assess the locomotor functional recovery of the hind limb. It was conducted in a child&#x2019;s circular plastic swimming pool (1.3&#xA0;m in diameter [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]). Cagemates (two animals) were placed in the center of the open field. They were observed for 5-min periods and scored for general locomotor ability using the standard BBB scale. The rats were rated on a scale of 0 to 21, 0 being no function and 21 being normal. If the animal stopped moving for a minute, it was placed again in the center of the open field; otherwise it was left undisturbed for the duration of the 5-min test period.</p>
        <p>Reflexes in the hind limbs were assessed with hind limb placing response (HLPR) and foot orienting response (FOR). They were each scored on a scale of 0 to 2, 0 indicating no function and 2 indicating full function [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. Half-scores were assigned if the behavioral response appeared intermediate. Hind limbs were scored separately for each measure. To assess HLPR, we grasped the hind foot between the thumb and forefinger, pulled backwards, and then released the foot. The placement of the foot on the table surface was then scored [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. The FOR followed Gruner&#x2019;s [<xref ref-type="bibr" rid="CR40">40</xref>] protocol modified from the previous descriptions of this reflex [<xref ref-type="bibr" rid="CR43">43</xref>]. When a rat is raised and lowered by the tail, it shows a characteristic behavior of the hind legs. A normal rat spreads the toes of its hind leg wide apart and generally holds them apart for several seconds. After spinal cord injury, this response is sometimes lost completely, or reduced in magnitude.</p>
        <p>The inclined plane test (IPT) measured the ability of the rats to maintain their position for 5&#xA0;s on an inclined plane, covered by a rubber mat containing horizontal ridges (1&#xA0;mm deep, spaced 3&#xA0;mm apart, self-made) [<xref ref-type="bibr" rid="CR44">44</xref>]. The rats were observed as the angle of the surface was increased from 5 to 90&#xB0; at 5&#xB0; intervals. The angle at which the rat could no longer stay in position was the outcome measure.</p>
        <p>Hind limb sensory function was tested by ability to perceive a standard application of a controlled stimulus to the trunk below the level of the lesion using a standard testing apparatus hot plate (IITC Life Science Inc., Woodland Hills, CA, USA) [<xref ref-type="bibr" rid="CR46">46</xref>]. The time taken for the rat to withdraw its hind paws from contact with the hot plate was noted. A cutoff time was about 20&#xA0;s after which the animals were removed to prevent thermal injury [<xref ref-type="bibr" rid="CR46">46</xref>].</p>
      </sec>
      <sec id="Sec6">
        <title>Recovery of lower urinary tract function</title>
        <p>Normal lower urinary tract (LUT) function involves both spinal and supraspinal circuitry that controls urine storage and release [<xref ref-type="bibr" rid="CR47">47</xref>]. Incomplete SCI results in an initial loss and later partial or complete recovery of LUT function depending on the severity of injury [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>].</p>
        <p>After SCI the rats were not capable initially of spontaneous micturition, and their bladders were manually expressed twice daily. The volume of expressed urine was measured each time, and the data were used to estimate the initiation of LUT function after SCI.</p>
      </sec>
      <sec id="Sec7">
        <title>Histological analysis</title>
        <p><bold>Tissue processing and immunohistochemical staining</bold> Twenty-eight days after SCI, animals were killed for histological and immunohistochemical analysis. Rats were deeply anesthetized with sodium pentobarbital (50&#x2013;60&#xA0;mg/kg b/w, i.p.) and perfused transcardially; first with 100&#xA0;ml 0.05&#xA0;M phosphate-buffed saline (PBS) containing 0.1% heparin, followed by 300&#x2013;500&#xA0;ml of 4% paraformaldehyde (PFA). The T9 to L1 segments of the spinal cords were removed and incubated in the same fixative solution overnight at 4&#xB0;C and then cryoprotected in PBS solution containing 30% sucrose. A segment of each cord, extending from 5&#xA0;mm rostral to 5&#xA0;mm caudal to the lesion site was embedded in medium (Tissue-Tek&#xAE; O.C.T. compound, Sakura Finetek USA, Inc., Torrrance, CA, USA). Serial sections were cut at 20-&#x3BC;m intervals on a cryostat and mounted onto slides (ColorFrost/Plus; Fisher, Pittsburgh, PA, USA) for histochemical staining. Some cords were transverse-sectioned for immunohistochemical analysis using the antibodies described in the section below. Longitudinal sections were cut for Luxol fast blue staining, a lipophilic dye used commonly to stain myelin [<xref ref-type="bibr" rid="CR38">38</xref>].Details of these immunohistochemical procedures have been described previously [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Briefly, the cryostat sections were thawed, air-dried, and then incubated in hydrogen peroxide to reduce endogenous peroxidase activity, before being rinsed in PBS. The sections were then incubated in 1% sodium borohydride for 15&#xA0;min. After thorough washing with PBS, the sections were treated with PBS/5% normal goat serum with 0.3% Triton X-100 at room temperature for 30&#xA0;min. Overnight incubation with primary antibody was performed in humidified boxes at 4&#xB0;C. Macrophages and reactive microglia were detected with a mouse monoclonal antibody against ED-1 (MCA 341R, 1:500; Serotec, Hornby, ON, Canada) and reactive astrocytes (astrogliosis) were determined with rabbit anti-glial fibrillary acidic protein (GFAP) polyclonal antibodies (Zymed&#xAE; Lab-SA System Kit, dilution was 1:600, Invitrogen Canada Inc., Burlington, ON, Canada). The following day, sections were rinsed with PBS and incubated with either rhodamine-conjugated or fluorescein isothiocyanate (FITC)-conjugated secondary antibodies. Sections were then rinsed, coverslipped, and examined under a confocal microscope.To determine the spared axons and myelin, double fluorescent immunolabeling was performed, combining mouse monoclonal antibodies against neurofilament (RT-97, 1:10; Developmental Hybridoma Bank) and rabbit anti-myelin basic protein (MBP) polyclonal antibodies (1:50; Chemicon Int., Temecula, CA, USA). For double immunolabeling, sections were developed using a mixture of FITC-conjugated goat anti-rabbit IgG and rhodamine-conjugated goat anti-mouse IgG in 1% normal goat serum and 0.25% Triton X-100; 1:200 (Invitrogen Canada Inc., Burlington, ON, Canada) for 2&#xA0;h. Sections were then rinsed, coverslipped, and examined under a confocal microscope. An investigator who was blinded to the treatment groups conducted histological analysis.</p>
        <p><bold>Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling assays and quantification</bold> For detection of apoptotic cells, a terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) stain was performed using the &#x201C;In situ Cell Death Detection Kit-Fluorescein&#x201D; (Roche Molecular Biochemicals, Chemicon Int., Temecula, CA, USA), according to the manufacturer&#x2019;s instructions. After fixation, tissue sections were incubated in TdT-mediated dUTP-biotin nick end labeling (TUNEL) reaction mixture containing TdT buffer with TdT and biotinylated dUTP in TdT buffer, incubated in a humid atmosphere at 37&#xB0;C for 90&#xA0;min, and then washed with PBS. The sections were incubated at room temperature (37&#xB0;C) for 30&#xA0;min with fluorescence-conjugated antibody. The results were analyzed using confocal fluorescence microscopy. TUNEL-positive cells in the lesion site in the spinal cord were quantified by counting positively stained cells. Sections (5&#x2013;7 per animal) taken from the penumbra of the lesion and spaced about 100&#xA0;&#x3BC;m apart were analyzed for each animal (<italic>n</italic>&#x2009;=&#x2009;3&#x2013;5 animals per group). Apoptotic cell death was determined by counting the total number of TUNEL-positive nuclei through entire cross sections. Low power sections were digitized and manually outlined using an image analysis system. Any cavities present in the sections were excluded from analysis. Data are expressed as cells per section [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
        <p><bold>Quantification</bold> For cell counting, 5&#x2013;7 sections from each animal (<italic>n</italic>&#x2009;=&#x2009;5 for each group) at the lesion site (every third section, 100&#xA0;&#x3BC;m apart) were analyzed. OX-42-positive microglia and TUNEL-positive nuclei were counted through the entire cross section. Data are expressed as the number of immunostained cells per section (mean &#xB1; SEM).</p>
      </sec>
      <sec id="Sec8">
        <title>Statistical analysis</title>
        <p>All data are presented as mean &#xB1; SEM. The statistical significance of behavioral scores was analyzed by Kruskal-Wallis nonparametric analysis of variance followed by Mann-Whitney U tests. Histological data were evaluated by Student&#x2019;s <italic>t</italic>-tests.</p>
      </sec>
    </sec>
    <sec id="Sec9" sec-type="results">
      <title>Results</title>
      <sec id="Sec10">
        <title>Guanosine improves neurological function</title>
        <p>Over the course of 4&#xA0;weeks after spinal cord injury, control rats (which received saline treatment) recovered occasional weight-supported plantar steps, but no fore-hind limb coordination, and had a mean BBB locomotor score of 9.3&#x2009;&#xB1;&#x2009;0.6 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). In contrast, the guanosine-treated rats recovered to a BBB score of 14&#x2009;&#xB1;&#x2009;0.5 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>); they exhibited consistent weight supporting with consistent fore-hind limb coordination. Hind limb locomotor function in guanosine-treated animals was significantly better than in rats that received saline treatment (<italic>P</italic>&#x2009;&lt;&#x2009;0.01).
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Open field walking test (OFWT) scores from day 0 (the same day as surgery, prior to treatment) to 28&#xA0;days after spinal cord injury for groups of saline- and guanosine-treated animals (means &#xB1; SEM). Animals with normal spinal cord function score 21, whereas a score of 0 represents total paralysis. Hind limb locomotor function in guanosine-treated animals (<italic>n</italic>&#x2009;=&#x2009;11) was significantly better than in rats that received saline treatment (<italic>n</italic>&#x2009;=&#x2009;10; <italic>P</italic>&#x2009;&lt;&#x2009;0.01) from day 1 to 28 after injury</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig1_HTML" id="MO1"/></fig></p>
        <p>Uninjured rats have normal HLPR scores of 2 [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]; they always place an extended hind limb briskly beneath the body in a proprioceptive placing response. Injured rats place their hind limb either partially, or unreliably, or not all, depending on the time since the injury and the treatment. In the present study, 4&#xA0;weeks after injury, control rats with saline injection attained a 1.0&#x2009;&#xB1;&#x2009;0.1&#xA0;HLPR score (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>) that was characterized by little or no attempt to place the foot, or leaving the foot extended with its dorsal surface down. In contrast, rats treated with guanosine reached a score of 1.7&#x2009;&#xB1;&#x2009;0.1 (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>), with the toes of their hind legs spread wide apart, a finding which is significantly better than rats that received saline treatment (<italic>P</italic>&#x2009;&lt;&#x2009;0.01). Uninjured rats have a normal FOR score of 2. Saline-treated animals had a FOR score of 1.0&#x2009;&#xB1;&#x2009;0.1 (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). These rats extended their hind legs laterally with toe spread but turned their feet outward. When these rats were lowered, they did not orient their feet toward the surface. In contrast, the guanosine-treated rats recovered to a score of 1.7&#x2009;&#xB1;&#x2009;0.1 (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>), which is significantly different (<italic>P</italic>&#x2009;&lt;&#x2009;0.01) from the saline-treated rats.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Hind limb placing response (HLPR) scores from day 0 (the same day as surgery, prior to treatment) to 28&#xA0;days after spinal cord injury for groups of saline- and guanosine-treated animals (means &#xB1; SEM). Animals with normal spinal cord function score 2, whereas a score of 0 represents total paralysis. Compared with saline-treated control animals (<italic>n</italic>&#x2009;=&#x2009;10), guanosine-treated animals (<italic>n</italic>&#x2009;=&#x2009;11) had a significantly better improvement of their hind limb placing responses (<italic>P</italic>&#x2009;&lt;&#x2009;0.01) from day 1 to 28 after injury</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Foot orienting response (FOR) scores from day 0 (the same day as surgery, prior to treatment) to 28&#xA0;days after spinal cord injury for groups of saline- and guanosine-treated animals (means &#xB1; SEM). Animals with normal spinal cord function score 2, whereas a score of 0 represents total paralysis. Compared with saline-treated control animals (<italic>n</italic>&#x2009;=&#x2009;10), guanosine-treated animals (<italic>n</italic>&#x2009;=&#x2009;11) had a significantly better improvement of their foot orienting responses (<italic>P</italic>&#x2009;&lt;&#x2009;0.01) from day 1 to 28 after injury</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig3_HTML" id="MO3"/></fig></p>
        <p>Uninjured rats maintain their position on the inclined plane even at an angle of 90&#xB0;. In the present study, saline-treated control rats recovered their ability to maintain their position at 69&#xB0;&#x2009;&#xB1;&#x2009;2 by 4&#xA0;weeks after injury, whereas guanosine-treated rats were able to maintain their position to a mean incline of 79&#xB0;&#x2009;&#xB1;&#x2009;1 (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>) by 4&#xA0;weeks (<italic>P</italic>&#x2009;&lt;&#x2009;0.05).
<fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Inclined plane test (IPT) scores from day 0 (the same day as surgery, prior to treatment) to 28&#xA0;days after spinal cord injury for groups of saline- and guanosine-treated animals (means &#xB1; SEM). Compared with saline-treated control animals (<italic>n</italic>&#x2009;=&#x2009;10), guanosine-treated animals (<italic>n</italic>&#x2009;=&#x2009;11) had a significantly better score in their inclined plane test (<italic>P</italic>&#x2009;&lt;&#x2009;0.05) from day 1 to 28 after injury</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig4_HTML" id="MO4"/></fig></p>
        <p>Both saline- and guanosine-treated rats were insensitive to the thermal stimulus using the hot plate test during the first 2&#xA0;days after injury. There was a gradual recovery of sensory function thereafter with recovery being accelerated in guanosine-treated animals compared to controls (<italic>P</italic>&#x2009;&lt;&#x2009;0.05) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>).
<fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Post-lesional sensitivity of hind limbs touched by a hot plate from day 0 (the same day as surgery, prior to treatment) to 28&#xA0;days after spinal cord injury for groups of saline- and guanosine-treated animals. Values are the means &#xB1; SEM of the average time of withdrawal of left and right hind paws during contact with a hot plate. Compared with saline-treated control animals (<italic>n</italic>&#x2009;=&#x2009;10), guanosine-treated animals (<italic>n</italic>&#x2009;=&#x2009;11) had a significantly better improvement of their sensory function (*<italic>P</italic>&#x2009;&lt;&#x2009;0.05) from day 2 to 14 after injury</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig5_HTML" id="MO5"/></fig></p>
      </sec>
      <sec id="Sec11">
        <title>Guanosine accelerated LUT functional recovery following SCI</title>
        <p>In saline-treated rats the volume of manually expressed urine increased over the first 7&#xA0;days after SCI and then decreased as spontaneous micturition was reestablished. On the basis of a previous study [<xref ref-type="bibr" rid="CR48">48</xref>], the increase in volume of expressed urine during the first week after injury was interpreted as resulting from increased bladder size in the absence of spontaneous micturition. The subsequent decrease in manually expressed urine indicates the initiation of spontaneous micturition (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>). In guanosine-treated rats there was a significantly lower residual urine volume compared to the saline-treated animals (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>; <italic>P</italic>&#x2009;&lt;&#x2009;0.001). More importantly, the rats that received guanosine recovered their LUT function completely by 7&#xA0;days after injury (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>).
<fig id="Fig6"><label>Fig.&#xA0;6</label><caption><p>Time course of recovery of lower urinary tract function (spontaneous voiding). Urinary bladders were expressed every 12&#xA0;h, and the collected urine volume was measured. Means &#xB1; SEM of the volume for each group. Compared with saline-treated control animals (<italic>n</italic>&#x2009;=&#x2009;10), guanosine-treated animals (<italic>n</italic>&#x2009;=&#x2009;11) had significantly less urine collected with time after SCI (*<italic>P</italic>&#x2009;&lt;&#x2009;0.05; **<italic>P</italic>&#x2009;&lt;&#x2009;0.001). The rats that received guanosine had empty bladders by day 7 after injury</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig6_HTML" id="MO6"/></fig></p>
      </sec>
      <sec id="Sec12">
        <title>Guanosine attenuates macrophage and microglia activation, but not astrogliosis</title>
        <p>After SCI, early inflammatory reactions consisting of neutrophil and macrophage invasion as well as activation of microglia and astrocytes were reported in earlier studies [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. In the present study, the activated macrophages and microglia were labeled by the ED-1 immunoreaction. Guanosine treatment decreased the number of the ED-1 immunopositive cells compared with saline treatment (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>a, b, e; <italic>P</italic>&#x2009;&lt;&#x2009;0.01). However, no differences were found between the saline and guanosine groups in the number of activated astroglia (astrogliosis) indicated by the GFAP immunostaining (Fig.&#xA0;<xref rid="Fig7" ref-type="fig">7</xref>c, d).
<fig id="Fig7"><label>Fig.&#xA0;7</label><caption><p>Fluorescent immunostaining using antibodies against a marker (ED-1) for macrophages and activated microglia in cross sections of cords from saline-treated (<bold>a</bold>) and guanosine-treated (<bold>b</bold>) animals at the lesion site 4&#xA0;weeks after injury. There were fewer ED-1-immunolabeled cells in cords of guanosine-treated rats (<bold>b</bold>, <bold>e</bold>) compared to the cords of vehicle-treated rats (<bold>a</bold>, <bold>e</bold>; <italic>P</italic>&#x2009;&lt;&#x2009;0.01). GFAP-immunofluorescent staining of cross sections of spinal cords from vehicle-treated (<bold>c</bold>) and guanosine-treated (<bold>d</bold>) animals at the lesion site 4&#xA0;weeks after injury showed no difference in immunostaining of GFAP between the cords of guanosine-treated rats (<bold>d</bold>) and vehicle-treated rats (<bold>c</bold>). <italic>Scale bar</italic>&#x2009;=&#x2009;50&#xA0;&#x3BC;m for all</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig7a-d_HTML" id="MO7"/></fig></p>
      </sec>
      <sec id="Sec13">
        <title>Guanosine attenuates apoptotic cell death in lesion site of spinal cord</title>
        <p>In the present study, apoptotic cell death induced by traumatic spinal cord injury was determined with TUNEL staining. TUNEL-positive nuclei were not uniformly distributed throughout the cross section of the spinal cord but were more numerous in the vicinity of the injury center. Quantification of TUNEL-positive nuclei showed that there were significantly fewer TUNEL-positive nuclei in the spinal cords of guanosine-treated rats than saline-treated control animals (Fig.&#xA0;<xref rid="Fig8" ref-type="fig">8</xref>; <italic>P</italic>&#x2009;&lt;&#x2009;0.001).
<fig id="Fig8"><label>Fig.&#xA0;8</label><caption><p>TUNEL-positive apoptotic cells in spinal cord lesions were quantified by counting the total number of TUNEL-positive nuclei through entire cross sections. Compared with the cords from saline-treated animals (<bold>a</bold>, <bold>c</bold>), guanosine-treated cords had significantly fewer TUNEL-positive cells (<bold>b</bold>, <bold>c</bold>; <italic>P</italic>&#x2009;&lt;&#x2009;0.001). <italic>Scale bar</italic>&#x2009;=&#x2009;50&#xA0;&#x3BC;m for both <bold>a</bold> and <bold>b</bold></p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig8_HTML" id="MO9"/></fig></p>
      </sec>
      <sec id="Sec14">
        <title>Guanosine increases axon and myelin sparing</title>
        <p>Axons were labeled with antibodies against RT-97 (a neuronal cytoskeletal protein; Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>a, b) and myelin was labeled with antibodies against MBP (a specific marker for myelin; Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>c, d). The immunohistochemistry showed that there were more axons (red, Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>b) and myelin (green, Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>d) as well as myelinated axons (yellow, Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>f) in the spinal cords from guanosine-treated animals than in the cords from saline-treated control rats (Fig.&#xA0;<xref rid="Fig9" ref-type="fig">9</xref>a, c, e), indicating that systemic administration of guanosine is associated with preservation of tissue including neuronal and glial elements.
<fig id="Fig9"><label>Fig.&#xA0;9</label><caption><p>Immunostaining with antibodies against RT-97 for labeling axons (<bold>a</bold>, <bold>b</bold>) and against myelin basic protein (MBP) for central myelin (<bold>c</bold>, <bold>d</bold>) at the lesion site demonstrated the spared tissue. Cross sections from saline-treated (<bold>a</bold>) and guanosine-treated cords (<bold>b</bold>) demonstrate a neurofilament (<italic>NF</italic>) immunoreactivity surrounding the lesion site. <bold>c</bold>, <bold>d</bold> Cross sections from saline-treated (<bold>c</bold>) and guanosine-treated cords reveal myelin at the lesion site. <bold>e</bold>, <bold>f</bold> Merger of the two images demonstrates NF (<italic>red</italic>) and MBP (<italic>green</italic>) double fluorescent immunolabeling. There were more spared axons and more myelin in the cords around the lesion site from guanosine-treated animals compared to the saline-treated group. <italic>Scale bar</italic>&#x2009;=&#x2009;50&#xA0;&#x3BC;m for all</p></caption><graphic position="anchor" xlink:href="11302_2007_9079_Fig9_HTML" id="MO10"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec15" sec-type="discussion">
      <title>Discussion</title>
      <p>These data are the first to demonstrate the ability of guanosine to act as a neuroprotective agent in vivo. These findings have potential clinical relevance. Previous studies have shown that after central nervous system injuries, the concentrations of guanosine are elevated around the injury and in CSF, sometimes for prolonged periods [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Given the various trophic and antiapoptotic effects of guanosine in vitro [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], it seemed likely that increasing the concentration of guanosine in the central nervous system after injury in vivo might also be neuroprotective. We found that within 7&#xA0;min of systemic administration, guanosine enters and progressively accumulates in the central nervous system (unpublished data), where it is converted to guanine. It remains to be determined whether guanosine, guanine, or both are the active neuroprotective agent. However, guanosine is more readily deliverable than guanine as a potential neuroprotectant.</p>
      <p>The model of incomplete spinal cord injury that we have used is clinically relevant since about 50% of patients with spinal trauma have incomplete injury [<xref ref-type="bibr" rid="CR53">53</xref>]. After incomplete spinal cord injury, both reflex and voluntary motor functions below the level of the injury are initially lost; partial recovery occurs over time [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. The recovery of functions mediated by supraspinally controlled reflexes is slow and incomplete since these require the function of long tracts, many of which are irreversibly damaged by the injury [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. Recovery of locomotion and limb placement depends on ascending and descending spinal cord tracts, including cortico-, rubro-, reticulo-, vestibulo-, and raphespinal tracts [<xref ref-type="bibr" rid="CR58">58</xref>]. The functional loss after spinal cord injury in rats involves interruption of descending serotonergic [<xref ref-type="bibr" rid="CR59">59</xref>], reticulospinal, and other descending spinal tracts that facilitate segmental reflexes [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. The ascending spinothalamic tracts mediate the perception of pain and temperature below the level of the lesion. Since all of these motor and sensory functions were better in guanosine-treated animals than in control animals, it appears that guanosine preserved the function of multiple long tracts. This was associated with increased axonal survival and myelin preservation.</p>
      <p>Normal micturition requires coordinated activation of the bladder smooth muscle (detrusor) and the striated muscle of the external urethral sphincter, controlled by spinal and supraspinal circuitry [<xref ref-type="bibr" rid="CR47">47</xref>]. Thus after incomplete spinal cord injury, initially bladder function is lost, but later partially recovers, the extent of recovery depending on the degree of preservation of white matter (and hence the long tracts) at the injury site [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Our data revealed that in guanosine-treated rats, residual urine volume was not only much less than in controls from the first day after the spinal cord injury, but that by 7&#xA0;days after spinal cord injury micturition had returned to normal. Because guanosine began to exert a neuroprotective effect on both motor and bladder function soon after it was first administered, its neuroprotective effect on each may involve similar mechanisms.</p>
      <p>The inherent complexity of the biological system coupled with the many potential trophic actions of guanosine make it difficult to determine the mechanisms by which guanosine produces its effects. Nevertheless, neuroprotective effects were observed by 24&#xA0;h after spinal cord injury. As guanosine was administered 4&#xA0;h post-injury, it must have affected processes that were important between 4 and 24&#xA0;h post-injury. Within this time frame after traumatic injury of the spinal cord, both inflammatory responses and apoptosis are prominent. Activation and proliferation of microglia/macrophages play an important role in the secondary damage following spinal cord injury. Thus, cells at the center of the injury cascade are potential targets for neuroprotective treatments of acute SCI [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR61">61</xref>]. As guanosine attenuated the activation and proliferation of microglia/macrophages following SCI, this may at least in part provide an explanation for its neuroprotective effect.</p>
      <p>Guanosine has antiapoptotic effects in vitro [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] and this is another potential mechanism through which guanosine might exert beneficial effects after spinal cord injury. Apoptosis after SCI has been described by many investigators [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR62">62</xref>&#x2013;<xref ref-type="bibr" rid="CR67">67</xref>]. In these reports, early apoptosis of neural cells, including neurons, is followed by a delayed wave of predominantly oligodendroglial-programmed cell death in degenerating white matter tracts [<xref ref-type="bibr" rid="CR63">63</xref>&#x2013;<xref ref-type="bibr" rid="CR67">67</xref>]. Studies of apoptosis in white matter after injury raise the possibility that glial apoptosis occurs, at least in part, as a consequence of axonal degeneration [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. However, the presence of activated microglia in contact with apoptotic oligodendrocytes after SCI indicates that this interaction may also activate cell death programs in the oligodendrocyte [<xref ref-type="bibr" rid="CR70">70</xref>]. Secondary axonal degeneration may then follow [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. In the present study, guanosine significantly suppressed apoptosis in the injured spinal cords when it was systemically administered daily for 2&#xA0;weeks beginning 4&#xA0;h after injury. It seems reasonable to postulate that decreasing apoptosis may be an important mechanism through which guanosine improves neurological outcome after SCI.</p>
      <p>Although the intracellular pathways through which guanosine suppresses apoptotic cell death following spinal cord injury are not known, a number of intracellular pathways which protect cells against apoptosis have been identified. These include the phosphatidylinositol 3-kinase (PI-3-K)/Akt/protein kinase B (PKB) pathway [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>] and the mitogen-activated protein (MAP) kinase pathway [<xref ref-type="bibr" rid="CR75">75</xref>]. Our previous studies in vitro have shown that the antiapoptotic effect of guanosine is mediated by the activation of both PI-3-K/Akt/PKB and MAPK pathways [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p>
      <p>Guanosine can also increase intracellular cAMP in various cell types [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>], and increases in cAMP after spinal cord injury have been shown to increase recovery [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. However, it appears unlikely that increases in intracellular cAMP are responsible for the effects of guanosine since the principal effect of cAMP in enhancing recovery from spinal cord injury appears to be due to its ability to promote axonal regeneration. In contrast, the neuroprotective effects we observed early after administration of guanosine are unlikely to be explained on the basis of outgrowth of damaged axons. A much longer time frame could be required for this to occur.</p>
      <p>A further possible mechanism by which guanosine might exert its neuroprotective effects is by stimulating cells to release and increase synthesis of various trophic factors, such as basic fibroblast growth factor (bFGF), nerve growth factor (NGF), and neurotrophin-3 (NT-3) [<xref ref-type="bibr" rid="CR28">28</xref>]. Such trophic factors can contribute to tissue preservation after trauma [<xref ref-type="bibr" rid="CR67">67</xref>]. The ability of guanosine to stimulate production and release of trophic factors may not only have early effects, but also may contribute to the reduced number of apoptotic cells observed 3&#xA0;weeks after the injury.</p>
      <p>This study is important not only because it is the first to demonstrate the neuroprotective effect of systemically administered guanosine in acute spinal cord injury, but also because it indicates some of the potential mechanisms whereby guanosine may exert its neuroprotective effects in vivo. This work provides a basis for further exploration of the purinergic mechanisms underlying the neuroprotective effects of exogenous guanosine. Furthermore, and of potential clinical importance, is that guanosine was effective when it was administered 4&#xA0;h after the injury&#x2014;a realistic time frame in which to initiate treatment after spinal cord injury in humans.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Dr. Raelene Kinlough-Rathbone for her helpful suggestions and critical appraisal of the manuscript. Shucui Jiang is recipient of a Chris Beehler Faculty Investigator Award from the Canadian Spinal Research Organization.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ackery</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tator</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Krassioukov</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A global perspective on spinal cord injury epidemiology</article-title>
          <source>J Neurotrauma</source>
          <year>2004</year>
          <volume>21</volume>
          <fpage>1355</fpage>
          <lpage>1370</lpage>
          <pub-id pub-id-type="doi">10.1089/neu.2004.21.1355</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ackery A, Tator C, Krassioukov A (2004) A global perspective on spinal cord injury epidemiology. J Neurotrauma 21:1355&#x2013;1370 <pub-id pub-id-type="pmid">15672627</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwab</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Bartholdi</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Degeneration and regeneration of axons in the lesioned spinal cord</article-title>
          <source>Physiol Rev</source>
          <year>1996</year>
          <volume>76</volume>
          <fpage>319</fpage>
          <lpage>370</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schwab ME, Bartholdi D (1996) Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 76:319&#x2013;370 <pub-id pub-id-type="pmid">8618960</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hulsebosch</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Recent advances in pathophysiology and treatment of spinal cord injury</article-title>
          <source>Adv Physiol Educ</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>238</fpage>
          <lpage>255</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hulsebosch CE (2002) Recent advances in pathophysiology and treatment of spinal cord injury. Adv Physiol Educ 26:238&#x2013;255 <pub-id pub-id-type="pmid">12443996</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nath</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wheeler</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Walter</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Urologic aspects of traumatic central cord syndrome</article-title>
          <source>J Am Paraplegia Soc</source>
          <year>1993</year>
          <volume>16</volume>
          <fpage>160</fpage>
          <lpage>164</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nath M, Wheeler JS Jr, Walter JS (1993) Urologic aspects of traumatic central cord syndrome. J Am Paraplegia Soc 16:160&#x2013;164 <pub-id pub-id-type="pmid">8366338</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Buttigieg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Guanosine promotes remyelination and functional recovery in chronic spinal injury</article-title>
          <source>Neuroreport</source>
          <year>2003</year>
          <volume>14</volume>
          <fpage>2463</fpage>
          <lpage>2467</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-200312190-00034</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Jiang S, Khan MI, Lu Y, Wang J, Buttigieg J, Werstiuk ES, Ciccarelli R, Caciagli F, Rathbone MP (2003) Guanosine promotes remyelination and functional recovery in chronic spinal injury. Neuroreport 14:2463&#x2013;2467 <pub-id pub-id-type="pmid">14663211</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tator</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Update on the pathophysiology and pathology of acute spinal cord injury</article-title>
          <source>Brain Pathol</source>
          <year>1995</year>
          <volume>5</volume>
          <fpage>407</fpage>
          <lpage>413</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tator CH (1995) Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 5:407&#x2013;413 <pub-id pub-id-type="pmid">8974623</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandler</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Tator</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Review of the effect of spinal cord trauma on the vessels and blood flow in the spinal cord</article-title>
          <source>J Neurosurg</source>
          <year>1976</year>
          <volume>45</volume>
          <fpage>638</fpage>
          <lpage>646</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sandler AN, Tator CH (1976) Review of the effect of spinal cord trauma on the vessels and blood flow in the spinal cord. J Neurosurg 45:638&#x2013;646 <pub-id pub-id-type="pmid">824416</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobrine</surname>
              <given-names>AI</given-names>
            </name>
          </person-group>
          <article-title>The neuronal theory of experimental traumatic spinal cord dysfunction</article-title>
          <source>Surg Neurol</source>
          <year>1975</year>
          <volume>3</volume>
          <fpage>261</fpage>
          <lpage>264</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kobrine AI (1975) The neuronal theory of experimental traumatic spinal cord dysfunction. Surg Neurol 3:261&#x2013;264 <pub-id pub-id-type="pmid">1154248</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>ED</given-names>
            </name>
          </person-group>
          <article-title>Pathophysiology of spinal cord trauma</article-title>
          <source>Ann Emerg Med</source>
          <year>1993</year>
          <volume>22</volume>
          <fpage>987</fpage>
          <lpage>992</lpage>
          <pub-id pub-id-type="doi">10.1016/S0196-0644(05)82739-8</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Anderson DK, Hall ED (1993) Pathophysiology of spinal cord trauma. Ann Emerg Med 22:987&#x2013;992 <pub-id pub-id-type="pmid">8503537</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Omura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Omura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hasegawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nagano</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Spatiotemporal quantification of recruit and resident macrophages after crush nerve injury utilizing immunohistochemistry</article-title>
          <source>Brain Res</source>
          <year>2005</year>
          <volume>1057</volume>
          <fpage>29</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2005.07.008</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Omura T, Omura K, Sano M, Sawada T, Hasegawa T, Nagano A (2005) Spatiotemporal quantification of recruit and resident macrophages after crush nerve injury utilizing immunohistochemistry. Brain Res 1057:29&#x2013;36 <pub-id pub-id-type="pmid">16112089</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popovich</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Stokes</surname>
              <given-names>BT</given-names>
            </name>
          </person-group>
          <article-title>Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats</article-title>
          <source>J Comp Neurol</source>
          <year>1997</year>
          <volume>377</volume>
          <fpage>443</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19970120)377:3&lt;443::AID-CNE10&gt;3.0.CO;2-S</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Popovich PG, Wei P, Stokes BT (1997) Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443&#x2013;464 <pub-id pub-id-type="pmid">8989657</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taoka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okajima</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Uchiba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Murakimi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kushimoto</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Johno</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nauro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Okabe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takatsuki</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Role of neutrophils in spinal cord injury in the rat</article-title>
          <source>Neuroscience</source>
          <year>1997</year>
          <volume>79</volume>
          <fpage>1177</fpage>
          <lpage>1182</lpage>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(97)00011-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Taoka Y, Okajima K, Uchiba M, Murakimi K, Kushimoto S, Johno M, Nauro M, Okabe H, Takatsuki K (1997) Role of neutrophils in spinal cord injury in the rat. Neuroscience 79:1177&#x2013;1182 <pub-id pub-id-type="pmid">9219976</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlson</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Parrish</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Springer</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Doty</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Dossett</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Acute inflammatory response in spinal cord following impact injury</article-title>
          <source>Exp Neurol</source>
          <year>1998</year>
          <volume>151</volume>
          <fpage>77</fpage>
          <lpage>88</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.1998.6785</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L (1998) Acute inflammatory response in spinal cord following impact injury. Exp Neurol 151:77&#x2013;88 <pub-id pub-id-type="pmid">9582256</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rice</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rivest</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yong</surname>
              <given-names>VW</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the early neuroinflammation after spinal cord injury in mice</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2007</year>
          <volume>66</volume>
          <fpage>184</fpage>
          <lpage>195</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rice T, Larsen J, Rivest S, Yong VW (2007) Characterization of the early neuroinflammation after spinal cord injury in mice. J Neuropathol Exp Neurol 66:184&#x2013;195 <pub-id pub-id-type="pmid">17356380</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Hermann</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Cell death in models of spinal cord injury</article-title>
          <source>Prog Brain Res</source>
          <year>2002</year>
          <volume>137</volume>
          <fpage>37</fpage>
          <lpage>47</lpage>
        </citation>
        <citation citation-type="display-unstructured">Beattie MS, Hermann GE, Rogers RC, Bresnahan JC (2002) Cell death in models of spinal cord injury. Prog Brain Res 137:37&#x2013;47 <pub-id pub-id-type="pmid">12440358</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Jakeman</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Stokes</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury</article-title>
          <source>Ann Neurol</source>
          <year>1999</year>
          <volume>45</volume>
          <fpage>120</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="doi">10.1002/1531-8249(199901)45:1&lt;120::AID-ART18&gt;3.0.CO;2-I</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Scott GS, Jakeman LB, Stokes BT, Szabo C (1999) Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann Neurol 45:120&#x2013;124 <pub-id pub-id-type="pmid">9894885</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein</article-title>
          <source>J Neurochem</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>2144</fpage>
          <lpage>2154</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0752144.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Liu D, Ling X, Wen J, Liu J (2000) The role of reactive nitrogen species in secondary spinal cord injury: formation of nitric oxide, peroxynitrite, and nitrated protein. J Neurochem 75:2144&#x2013;2154 <pub-id pub-id-type="pmid">11032904</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Ku</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Beckman</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>XM</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>iNOS and nitrotyrosine expression after spinal cord injury</article-title>
          <source>J Neurotrauma</source>
          <year>2001</year>
          <volume>18</volume>
          <fpage>523</fpage>
          <lpage>532</lpage>
          <pub-id pub-id-type="doi">10.1089/089771501300227323</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Xu J, Kim GM, Chen S, Yan P, Ahmed SH, Ku G, Beckman JS, Xu XM, Hsu CY (2001) iNOS and nitrotyrosine expression after spinal cord injury. J Neurotrauma 18:523&#x2013;532 <pub-id pub-id-type="pmid">11393255</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grossman</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Wrathall</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion</article-title>
          <source>Exp Neurol</source>
          <year>2001</year>
          <volume>168</volume>
          <fpage>273</fpage>
          <lpage>282</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.2001.7628</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Grossman SD, Rosenberg LJ, Wrathall JR (2001) Temporal-spatial pattern of acute neuronal and glial loss after spinal cord contusion. Exp Neurol 168:273&#x2013;282 <pub-id pub-id-type="pmid">11259115</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Taoka</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okajima</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Spinal cord injury in the rat</article-title>
          <source>Prog Neurobiol</source>
          <year>1998</year>
          <volume>56</volume>
          <fpage>341</fpage>
          <lpage>358</lpage>
          <pub-id pub-id-type="doi">10.1016/S0301-0082(98)00049-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Taoka Y, Okajima K (1998) Spinal cord injury in the rat. Prog Neurobiol 56:341&#x2013;358 <pub-id pub-id-type="pmid">9770243</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagg</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Oudega</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Degenerative and spontaneous regenerative processes after spinal cord injury</article-title>
          <source>J Neurotrauma</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>264</fpage>
          <lpage>280</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hagg T, Oudega M (2006) Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 23:264&#x2013;280 <pub-id pub-id-type="pmid">16629615</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teng</surname>
              <given-names>YD</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Onario</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Desilets</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Lan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Woodard</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>EY</given-names>
            </name>
            <name>
              <surname>Eichler</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Friedlander</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>3071</fpage>
          <lpage>3076</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0306239101</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM (2004) Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. Proc Natl Acad Sci U S A 101:3071&#x2013;3076 <pub-id pub-id-type="pmid">14981254</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scott</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Cuzzocrea</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Genovese</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kopriwski</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hooper</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>Uric acid protects against secondary damage after spinal cord injury</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>3483</fpage>
          <lpage>3488</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0500307102</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Scott GS, Cuzzocrea S, Genovese T, Kopriwski H, Hooper DC (2005) Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci U S A 102:3483&#x2013;3488 <pub-id pub-id-type="pmid">15728348</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kyung</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Gon</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Geun</surname>
              <given-names>KY</given-names>
            </name>
            <name>
              <surname>Sup</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Suk</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury</article-title>
          <source>Eur J Neurosci</source>
          <year>2006</year>
          <volume>24</volume>
          <fpage>1042</fpage>
          <lpage>1052</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04908.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kyung KS, Gon JH, Geun KY, Sup JJ, Suk WJ, Ho KJ (2006) 6-Shogaol, a natural product, reduces cell death and restores motor function in rat spinal cord injury. Eur J Neurosci 24:1042&#x2013;1052 <pub-id pub-id-type="pmid">16930431</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Casha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Fehlings</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury</article-title>
          <source>Exp Neurol</source>
          <year>2005</year>
          <volume>196</volume>
          <fpage>390</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1016/j.expneurol.2005.08.020</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Casha S, Yu WR, Fehlings MG (2005) FAS deficiency reduces apoptosis, spares axons and improves function after spinal cord injury. Exp Neurol 196:390&#x2013;400 <pub-id pub-id-type="pmid">16202410</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nikulina</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tidwell</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Dai</surname>
              <given-names>HN</given-names>
            </name>
            <name>
              <surname>Bregman</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Filbin</surname>
              <given-names>MT</given-names>
            </name>
          </person-group>
          <article-title>The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>8786</fpage>
          <lpage>8790</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0402595101</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Nikulina E, Tidwell JL, Dai HN, Bregman BS, Filbin MT (2004) The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci U S A 101:8786&#x2013;8790 <pub-id pub-id-type="pmid">15173585</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Filbin</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Tuszynski</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury</article-title>
          <source>J Neurosci</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>6402</fpage>
          <lpage>6409</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1492-04.2004</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Lu P, Yang H, Jones LL, Filbin MT, Tuszynski MH (2004) Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 24:6402&#x2013;6409 <pub-id pub-id-type="pmid">15254096</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Gysbers</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>MAR</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Trophic effects of purines in neurons and glia cells</article-title>
          <source>Prog Neurobiol</source>
          <year>1999</year>
          <volume>59</volume>
          <fpage>663</fpage>
          <lpage>690</lpage>
          <pub-id pub-id-type="doi">10.1016/S0301-0082(99)00017-9</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MAR, Reed JK, Ciccarelli R, Di Iorio P, Caciagli F (1999) Trophic effects of purines in neurons and glia cells. Prog Neurobiol 59:663&#x2013;690 <pub-id pub-id-type="pmid">10845757</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Giuliani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sperling</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Zoref-Shani</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Benowitz</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Traversa</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Bombi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Florio</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Virgilio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Crocker</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Purine nucleosides protect injured neurons and stimulate neuronal regeneration by intracellular and membrane receptor-mediated mechanisms</article-title>
          <source>Drug Dev Res</source>
          <year>2001</year>
          <volume>52</volume>
          <fpage>303</fpage>
          <lpage>315</lpage>
          <pub-id pub-id-type="doi">10.1002/ddr.1128</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Di Iorio P, Caciagli F, Giuliani P, Ballerini P, Ciccarelli R, Sperling O, Zoref-Shani E, Benowitz L, Traversa U, Bombi G, Florio T, Virgilio A, Andrew CM, Crocker CE, Werstiuk ES, Middlemiss PJ, Rathbone MP (2001) Purine nucleosides protect injured neurons and stimulate neuronal regeneration by intracellular and membrane receptor-mediated mechanisms. Drug Dev Res 52:303&#x2013;315 </citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nargi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Buccella</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Giuliani</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>D&#x2019;Alimonte</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Fischione</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Masciulli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Romano</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>P2Y2 receptor up-regulation induced by guanosine or UTP in rat brain cultured astrocytes</article-title>
          <source>Int J Immunopathol Pharmacol</source>
          <year>2006</year>
          <volume>19</volume>
          <fpage>293</fpage>
          <lpage>308</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ballerini P, Di Iorio P, Caciagli F, Rathbone MP, Jiang S, Nargi E, Buccella S, Giuliani P, D&#x2019;Alimonte I, Fischione G, Masciulli A, Romano S, Ciccarelli R (2006) P2Y2 receptor up-regulation induced by guanosine or UTP in rat brain cultured astrocytes. Int J Immunopathol Pharmacol 19:293&#x2013;308 <pub-id pub-id-type="pmid">16831297</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#x2019;Alimonte</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Flati</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>D&#x2019;Auro</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Toniato</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Martinotti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Guanosine inhibits CD40 receptor expression and function induced by cytokines and &#x3B2; amyloid in mouse microglia cells</article-title>
          <source>J Immunol</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>720</fpage>
          <lpage>731</lpage>
        </citation>
        <citation citation-type="display-unstructured">D&#x2019;Alimonte I, Flati V, D&#x2019;Auro M, Toniato E, Martinotti S, Rathbone MP, Jiang S, Ballerini P, Caciagli F, Ciccarelli R (2007) Guanosine inhibits CD40 receptor expression and function induced by cytokines and &#x3B2; amyloid in mouse microglia cells. J Immunol 178:720&#x2013;731 <pub-id pub-id-type="pmid">17202332</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loeffler</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>LeWitt</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Juneau</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Camp</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>DeMaggio</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Milburg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Matson</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Altered guanosine and guanine concentrations in rabbit striatum following increased dopamine turnover</article-title>
          <source>Brain Res Bull</source>
          <year>1998</year>
          <volume>45</volume>
          <fpage>297</fpage>
          <lpage>299</lpage>
          <pub-id pub-id-type="doi">10.1016/S0361-9230(97)00367-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Loeffler DA, LeWitt PA, Juneau PL, Camp DM, DeMaggio AJ, Milburg P, Matson WR, Rathbone MP (1998) Altered guanosine and guanine concentrations in rabbit striatum following increased dopamine turnover. Brain Res Bull 45:297&#x2013;299 <pub-id pub-id-type="pmid">9510422</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hindley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>DiIorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Guanosine stimulates neurite outgrowth in PC12 cells via activation of heme oxygenase and cyclic GMP</article-title>
          <source>Purinergic Signalling</source>
          <year>2005</year>
          <volume>1</volume>
          <fpage>161</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="doi">10.1007/s11302-005-6214-0</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bau C, Middlemiss PJ, Jiang S, Hindley S, Ciccarelli RS, Caciagli F, DiIorio P, Werstiuk ES, Rathbone MP (2005) Guanosine stimulates neurite outgrowth in PC12 cells via activation of heme oxygenase and cyclic GMP. Purinergic Signalling 1:161&#x2013;172 </citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iorio</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Traversa</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Nicoletti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>D&#x2019;Alimonte</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kleywegt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes</article-title>
          <source>Glia</source>
          <year>2004</year>
          <volume>46</volume>
          <fpage>356</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.20002</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Di Iorio P, Ballerini P, Traversa U, Nicoletti F, D&#x2019;Alimonte I, Kleywegt S, Werstiuk ES, Rathbone MP, Caciagli F, Ciccarelli R (2004) The antiapoptotic effect of guanosine is mediated by the activation of the PI 3-kinase/AKT/PKB pathway in cultured rat astrocytes. Glia 46:356&#x2013;368 <pub-id pub-id-type="pmid">15095366</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pettifer</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Kleywegt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bau</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Ramsbottom</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Vertes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ciccarelli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis</article-title>
          <source>Neuroreport</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>833</fpage>
          <lpage>836</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-200404090-00019</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Pettifer KM, Kleywegt S, Bau CJ, Ramsbottom JD, Vertes E, Ciccarelli R, Caciagli F, Werstiuk ES, Rathbone MP (2004) Guanosine protects SH-SY5Y cells against beta-amyloid-induced apoptosis. Neuroreport 15:833&#x2013;836 <pub-id pub-id-type="pmid">15073525</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>DeLuca</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jovetich</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Extracellular guanosine increases astrocyte cAMP: inhibition by adenosine A2 antagonists</article-title>
          <source>Neuroreport</source>
          <year>1991</year>
          <volume>2</volume>
          <fpage>661</fpage>
          <lpage>664</lpage>
          <pub-id pub-id-type="doi">10.1097/00001756-199111000-00007</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Rathbone MP, Middlemiss PJ, DeLuca B, Jovetich M (1991) Extracellular guanosine increases astrocyte cAMP: inhibition by adenosine A2 antagonists. Neuroreport 2:661&#x2013;664 <pub-id pub-id-type="pmid">1667270</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gysbers</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms</article-title>
          <source>Neurosci Lett</source>
          <year>1996</year>
          <volume>220</volume>
          <fpage>175</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.1016/S0304-3940(96)13253-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gysbers JW, Rathbone MP (1996) Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms. Neurosci Lett 220:175&#x2013;178 <pub-id pub-id-type="pmid">8994221</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khan</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Middlemiss</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Werstiuk</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Crocker</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Ciccarlli</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caciagli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rathbone</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats</article-title>
          <source>Int J Immunopathol Pharmacol</source>
          <year>2004</year>
          <volume>17</volume>
          <fpage>353</fpage>
          <lpage>366</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jiang S, Khan MI, Middlemiss PJ, Lu Y, Werstiuk ES, Crocker CE, Ciccarlli R, Caciagli F, Rathbone MP (2004) AIT-082 and methylprednisolone singly, but not in combination, enhance functional and histological improvement after acute spinal cord injury in rats. Int J Immunopathol Pharmacol 17:353&#x2013;366 <pub-id pub-id-type="pmid">15461869</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blight</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology</article-title>
          <source>J Neurol Sci</source>
          <year>1991</year>
          <volume>103</volume>
          <fpage>156</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="doi">10.1016/0022-510X(91)90159-5</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Blight AR (1991) Morphometric analysis of a model of spinal cord injury in guinea pigs, with behavioral evidence of delayed secondary pathology. J Neurol Sci 103:156&#x2013;171 <pub-id pub-id-type="pmid">1880533</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruner</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Blight</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression</article-title>
          <source>Brain Res</source>
          <year>1996</year>
          <volume>729</volume>
          <fpage>90</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="doi">10.1016/0006-8993(96)00366-6</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gruner JA, Yee AK, Blight AR (1996) Histological and functional evaluation of experimental spinal cord injury: evidence of a stepwise response to graded compression. Brain Res 729:90&#x2013;101 <pub-id pub-id-type="pmid">8874880</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basso</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>A sensitive and reliable locomotor rating scale for open field testing in rats</article-title>
          <source>J Neurotrauma</source>
          <year>1995</year>
          <volume>12</volume>
          <fpage>1</fpage>
          <lpage>21</lpage>
        </citation>
        <citation citation-type="display-unstructured">Basso DM, Beattie MS, Bresnahan JC (1995) A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12:1&#x2013;21 <pub-id pub-id-type="pmid">7783230</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basso</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection</article-title>
          <source>Exp Neurol</source>
          <year>1996</year>
          <volume>139</volume>
          <fpage>244</fpage>
          <lpage>256</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.1996.0098</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244&#x2013;256 <pub-id pub-id-type="pmid">8654527</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kerasidis</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wrathall</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Gale</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Behavioral assessment of functional deficit in rats with contusive spinal cord injury</article-title>
          <source>J Neurosci Methods</source>
          <year>1987</year>
          <volume>20</volume>
          <fpage>167</fpage>
          <lpage>179</lpage>
          <pub-id pub-id-type="doi">10.1016/0165-0270(87)90048-3</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Kerasidis H, Wrathall JR, Gale K (1987) Behavioral assessment of functional deficit in rats with contusive spinal cord injury. J Neurosci Methods 20:167&#x2013;179 <pub-id pub-id-type="pmid">3600032</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rivlin</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Tator</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Objective clinical assessment of motor function after experimental spinal cord injury in the rat</article-title>
          <source>J Neurosurg</source>
          <year>1977</year>
          <volume>47</volume>
          <fpage>577</fpage>
          <lpage>581</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rivlin AS, Tator CH (1977) Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg 47:577&#x2013;581 <pub-id pub-id-type="pmid">903810</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Todd</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Noyes</surname>
              <given-names>DH</given-names>
            </name>
          </person-group>
          <article-title>A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device</article-title>
          <source>Exp Neurol</source>
          <year>1987</year>
          <volume>95</volume>
          <fpage>548</fpage>
          <lpage>570</lpage>
          <pub-id pub-id-type="doi">10.1016/0014-4886(87)90299-8</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bresnahan JC, Beattie MS, Todd FD III, Noyes DH (1987) A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device. Exp Neurol 95:548&#x2013;570 <pub-id pub-id-type="pmid">3817079</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dadure</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vergnes</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Capdevila</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Intrathecal bupivacaine protects against extension of lesions in an acute contusive spinal cord injury model</article-title>
          <source>Eur J Anaesthesiol</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>793</fpage>
          <lpage>800</lpage>
          <pub-id pub-id-type="doi">10.1017/S0265021506000615</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Lopez S, Dadure C, Vergnes C, Capdevila X (2006) Intrathecal bupivacaine protects against extension of lesions in an acute contusive spinal cord injury model. Eur J Anaesthesiol 23:793&#x2013;800 <pub-id pub-id-type="pmid">16723046</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Groat</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>Central neural control of the lower urinary tract</article-title>
          <source>Ciba Found Symp</source>
          <year>1990</year>
          <volume>151</volume>
          <fpage>27</fpage>
          <lpage>44</lpage>
        </citation>
        <citation citation-type="display-unstructured">de Groat WC (1990) Central neural control of the lower urinary tract. Ciba Found Symp 151:27&#x2013;44; discussion 44&#x2013;56 <pub-id pub-id-type="pmid">2226064</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pikov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gillis</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Jasmin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wrathall</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Assessment of lower urinary tract functional deficit in rats with contusive spinal cord injury</article-title>
          <source>J Neurotrauma</source>
          <year>1998</year>
          <volume>15</volume>
          <fpage>375</fpage>
          <lpage>386</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pikov V, Gillis RA, Jasmin L, Wrathall JR (1998) Assessment of lower urinary tract functional deficit in rats with contusive spinal cord injury. J Neurotrauma 15:375&#x2013;386 <pub-id pub-id-type="pmid">9605351</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pikov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Wrathall</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Coordination of the bladder detrusor and the external urethral sphincter in a rat model of spinal cord injury: effect of injury severity</article-title>
          <source>J Neurosci</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>559</fpage>
          <lpage>569</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pikov V, Wrathall JR (2001) Coordination of the bladder detrusor and the external urethral sphincter in a rat model of spinal cord injury: effect of injury severity. J Neurosci 21:559&#x2013;569 <pub-id pub-id-type="pmid">11160435</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dusart</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schwab</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord</article-title>
          <source>Eur J Neurosci</source>
          <year>1994</year>
          <volume>6</volume>
          <fpage>712</fpage>
          <lpage>724</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1460-9568.1994.tb00983.x</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Dusart I, Schwab ME (1994) Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 6:712&#x2013;724 <pub-id pub-id-type="pmid">8075816</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merola</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>O&#x2019;Brien</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Castro</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Eule</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Lowe</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Dwyer</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Haher</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Espat</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Histologic characterization of acute spinal cord injury treated with intravenous methylprednisolone</article-title>
          <source>J Orthop Trauma</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>155</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="doi">10.1097/00005131-200203000-00003</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Merola A, O&#x2019;Brien MF, Castro BA, Smith DA, Eule JM, Lowe TG, Dwyer AP, Haher TR, Espat NJ (2002) Histologic characterization of acute spinal cord injury treated with intravenous methylprednisolone. J Orthop Trauma 16:155&#x2013;161 <pub-id pub-id-type="pmid">11880777</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Uemura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Matson</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Neurochemical analysis of focal ischemia in rats</article-title>
          <source>Stroke</source>
          <year>1991</year>
          <volume>22</volume>
          <fpage>1548</fpage>
          <lpage>1553</lpage>
        </citation>
        <citation citation-type="display-unstructured">Uemura Y, Miller JM, Matson WR, Beal MF (1991) Neurochemical analysis of focal ischemia in rats. Stroke 22:1548&#x2013;1553 <pub-id pub-id-type="pmid">1720576</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bracken</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Shepard</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Holford</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Baskin</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Eisenberg</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Flamm</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Leo-Summers</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Maroon</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study</article-title>
          <source>N Engl J Med</source>
          <year>1990</year>
          <volume>322</volume>
          <fpage>1405</fpage>
          <lpage>1411</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, Eisenberg HM, Flamm E, Leo-Summers L, Maroon J et al (1990) A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 322:1405&#x2013;1411 <pub-id pub-id-type="pmid">2278545</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gale</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kerasidis</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wrathall</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment</article-title>
          <source>Exp Neurol</source>
          <year>1985</year>
          <volume>88</volume>
          <fpage>123</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="doi">10.1016/0014-4886(85)90118-9</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Gale K, Kerasidis H, Wrathall JR (1985) Spinal cord contusion in the rat: behavioral analysis of functional neurologic impairment. Exp Neurol 88:123&#x2013;134 <pub-id pub-id-type="pmid">3979506</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ko</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Ditunno</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Graziani</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Little</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>The pattern of reflex recovery during spinal shock</article-title>
          <source>Spinal Cord</source>
          <year>1999</year>
          <volume>37</volume>
          <fpage>402</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.sc.3100840</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Ko HY, Ditunno JF Jr, Graziani V, Little JW (1999) The pattern of reflex recovery during spinal shock. Spinal Cord 37:402&#x2013;409 <pub-id pub-id-type="pmid">10432259</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leis</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Kronenberg</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Stetkarova</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Paske</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Stokic</surname>
              <given-names>DS</given-names>
            </name>
          </person-group>
          <article-title>Spinal motoneuron excitability after acute spinal cord injury in humans</article-title>
          <source>Neurology</source>
          <year>1996</year>
          <volume>47</volume>
          <fpage>231</fpage>
          <lpage>237</lpage>
        </citation>
        <citation citation-type="display-unstructured">Leis AA, Kronenberg MF, Stetkarova I, Paske WC, Stokic DS (1996) Spinal motoneuron excitability after acute spinal cord injury in humans. Neurology 47:231&#x2013;237 <pub-id pub-id-type="pmid">8710084</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiersemenzel</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Curt</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>From spinal shock to spasticity: neuronal adaptations to a spinal cord injury</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>54</volume>
          <fpage>1574</fpage>
          <lpage>1582</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hiersemenzel LP, Curt A, Dietz V (2000) From spinal shock to spasticity: neuronal adaptations to a spinal cord injury. Neurology 54:1574&#x2013;1582 <pub-id pub-id-type="pmid">10762496</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basso</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Neuroanatomical substrates of functional recovery after experimental spinal cord injury: implications of basic science research for human spinal cord injury</article-title>
          <source>Phys Ther</source>
          <year>2000</year>
          <volume>80</volume>
          <fpage>808</fpage>
          <lpage>817</lpage>
        </citation>
        <citation citation-type="display-unstructured">Basso DM (2000) Neuroanatomical substrates of functional recovery after experimental spinal cord injury: implications of basic science research for human spinal cord injury. Phys Ther 80:808&#x2013;817 <pub-id pub-id-type="pmid">10911417</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saruhashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Effect of mianserin on locomotory function after thoracic spinal cord hemisection in rats</article-title>
          <source>Exp Neurol</source>
          <year>1994</year>
          <volume>129</volume>
          <fpage>207</fpage>
          <lpage>216</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.1994.1162</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Saruhashi Y, Young W (1994) Effect of mianserin on locomotory function after thoracic spinal cord hemisection in rats. Exp Neurol 129:207&#x2013;216 <pub-id pub-id-type="pmid">7957735</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Faden</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Salzman</surname>
              <given-names>SK</given-names>
            </name>
          </person-group>
          <source>The neurobiology of central nervous system trauma</source>
          <year>1994</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Oxford University Press</publisher-name>
          <fpage>227</fpage>
          <lpage>244</lpage>
        </citation>
        <citation citation-type="display-unstructured">Faden A, Salzman SK (1994) The neurobiology of central nervous system trauma. Oxford University Press, New York, pp 227&#x2013;244 </citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>ZY</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats</article-title>
          <source>Brain Res</source>
          <year>2007</year>
          <volume>1135</volume>
          <fpage>177</fpage>
          <lpage>185</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2006.11.085</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Tian DS, Xie MJ, Yu ZY, Zhang Q, Wang YH, Chen B, Chen C, Wang W (2007) Cell cycle inhibition attenuates microglia induced inflammatory response and alleviates neuronal cell death after spinal cord injury in rats. Brain Res 1135:177&#x2013;185 <pub-id pub-id-type="pmid">17188663</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Casha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Fehlings</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat</article-title>
          <source>Neuroscience</source>
          <year>2001</year>
          <volume>103</volume>
          <fpage>203</fpage>
          <lpage>218</lpage>
          <pub-id pub-id-type="doi">10.1016/S0306-4522(00)00538-8</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Casha S, Yu WR, Fehlings MG (2001) Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103:203&#x2013;218 <pub-id pub-id-type="pmid">11311801</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crowe</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Shuman</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Masters</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys</article-title>
          <source>Nat Med</source>
          <year>1997</year>
          <volume>3</volume>
          <fpage>73</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="doi">10.1038/nm0197-73</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3:73&#x2013;76 <pub-id pub-id-type="pmid">8986744</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Emery</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Aldana</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bunge</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Puckett</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Keane</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Bethea</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Levi</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis after traumatic human spinal cord injury</article-title>
          <source>J Neurosurg</source>
          <year>1998</year>
          <volume>89</volume>
          <fpage>911</fpage>
          <lpage>920</lpage>
        </citation>
        <citation citation-type="display-unstructured">Emery E, Aldana P, Bunge MB, Puckett W, Srinivasan A, Keane RW, Bethea J, Levi AD (1998) Apoptosis after traumatic human spinal cord injury. J Neurosurg 89:911&#x2013;920 <pub-id pub-id-type="pmid">9833815</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>XZ</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>XM</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>SX</given-names>
            </name>
            <name>
              <surname>McDonald</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>HX</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>YJ</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Jacquin</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Neuronal and glial apoptosis after traumatic spinal cord injury</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>5395</fpage>
          <lpage>5406</lpage>
        </citation>
        <citation citation-type="display-unstructured">Liu XZ, Xu XM, Hu R, Du C, Zhang SX, McDonald JW, Dong HX, Wu YJ, Fan GS, Jacquin MF, Hsu CY, Choi DW (1997) Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci 17:5395&#x2013;5406 <pub-id pub-id-type="pmid">9204923</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yong</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Zoubine</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Citron</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Berman</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Festoff</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis in cellular compartments of rat spinal cord after severe contusion injury</article-title>
          <source>J Neurotrauma</source>
          <year>1998</year>
          <volume>15</volume>
          <fpage>459</fpage>
          <lpage>472</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yong C, Arnold PM, Zoubine MN, Citron BA, Watanabe I, Berman NE, Festoff BW (1998) Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. J Neurotrauma 15:459&#x2013;472 <pub-id pub-id-type="pmid">9674550</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McDonald</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Belegu</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Demyelination and remyelination after spinal cord injury</article-title>
          <source>J Neurotrauma</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>345</fpage>
          <lpage>359</lpage>
          <pub-id pub-id-type="doi">10.1089/neu.2006.23.345</pub-id>
        </citation>
        <citation citation-type="display-unstructured">McDonald JW, Belegu V (2006) Demyelination and remyelination after spinal cord injury. J Neurotrauma 23:345&#x2013;359 <pub-id pub-id-type="pmid">16629621</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abe</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sugiyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kayama</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kumagai</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Apoptotic cells associated with Wallerian degeneration after experimental spinal cord injury: a possible mechanism of oligodendroglial death</article-title>
          <source>J Neurotrauma</source>
          <year>1999</year>
          <volume>16</volume>
          <fpage>945</fpage>
          <lpage>952</lpage>
        </citation>
        <citation citation-type="display-unstructured">Abe Y, Yamamoto T, Sugiyama Y, Watanabe T, Saito N, Kayama H, Kumagai T (1999) Apoptotic cells associated with Wallerian degeneration after experimental spinal cord injury: a possible mechanism of oligodendroglial death. J Neurotrauma 16:945&#x2013;952 <pub-id pub-id-type="pmid">10547103</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warden</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bamber</surname>
              <given-names>NI</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Esposito</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ahmad</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>XM</given-names>
            </name>
          </person-group>
          <article-title>Delayed glial cell death following wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats</article-title>
          <source>Exp Neurol</source>
          <year>2001</year>
          <volume>168</volume>
          <fpage>213</fpage>
          <lpage>224</lpage>
          <pub-id pub-id-type="doi">10.1006/exnr.2000.7622</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Warden P, Bamber NI, Li H, Esposito A, Ahmad KA, Hsu CY, Xu XM (2001) Delayed glial cell death following wallerian degeneration in white matter tracts after spinal cord dorsal column cordotomy in adult rats. Exp Neurol 168:213&#x2013;224 <pub-id pub-id-type="pmid">11259109</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shuman</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Bresnahan</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Beattie</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats</article-title>
          <source>J Neurosci Res</source>
          <year>1997</year>
          <volume>50</volume>
          <fpage>798</fpage>
          <lpage>808</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19971201)50:5&lt;798::AID-JNR16&gt;3.0.CO;2-Y</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Shuman SL, Bresnahan JC, Beattie MS (1997) Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 50:798&#x2013;808 <pub-id pub-id-type="pmid">9418967</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bjartmar</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Trapp</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title>Axonal pathology in myelin disorders</article-title>
          <source>J Neurocytol</source>
          <year>1999</year>
          <volume>28</volume>
          <fpage>383</fpage>
          <lpage>395</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1007010205037</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bjartmar C, Yin X, Trapp BD (1999) Axonal pathology in myelin disorders. J Neurocytol 28:383&#x2013;395 <pub-id pub-id-type="pmid">10739578</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yin</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>TO</given-names>
            </name>
            <name>
              <surname>Griffin</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Roder</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Trapp</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title>Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>1953</fpage>
          <lpage>1962</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yin X, Crawford TO, Griffin JW, Tu P, Lee VM, Li C, Roder J, Trapp BD (1998) Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci 18:1953&#x2013;1962 <pub-id pub-id-type="pmid">9482781</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>TO</given-names>
            </name>
            <name>
              <surname>Rittenhouse</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Tsichlis</surname>
              <given-names>PN</given-names>
            </name>
          </person-group>
          <article-title>AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation</article-title>
          <source>Annu Rev Biochem</source>
          <year>1999</year>
          <volume>68</volume>
          <fpage>965</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.biochem.68.1.965</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Chan TO, Rittenhouse SE, Tsichlis PN (1999) AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 68:965&#x2013;1014 <pub-id pub-id-type="pmid">10872470</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cantley</surname>
              <given-names>LC</given-names>
            </name>
          </person-group>
          <article-title>The phosphoinositide 3-kinase pathway</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>296</volume>
          <fpage>1655</fpage>
          <lpage>1657</lpage>
          <pub-id pub-id-type="doi">10.1126/science.296.5573.1655</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296:1655&#x2013;1657 <pub-id pub-id-type="pmid">12040186</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Brunet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>West</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Datta</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Takasu</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms</article-title>
          <source>Science</source>
          <year>1999</year>
          <volume>286</volume>
          <fpage>1358</fpage>
          <lpage>1362</lpage>
          <pub-id pub-id-type="doi">10.1126/science.286.5443.1358</pub-id>
        </citation>
        <citation citation-type="display-unstructured">Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286:1358&#x2013;1362 <pub-id pub-id-type="pmid">10558990</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>